In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates
Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence
Tags: antifungal, CYP2C19 inhibitor, CYP51A1 inhibitor, Diflucan®, first-generation triazole
BASi Method Number SAP.1515
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
